Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roy Beveridge

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of the National Comprehensive Cancer Network : JNCCN|May 25, 2013
Roundtable--the changing oncology landscape: evolution or revolution?Roy Beveridge, John Fox, Susan A Higgins, et al.
Experimental Hematology|September 13, 2002
The effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) on platelet recovery in breast cancer patients undergoing autologous bone marrow transplantationMichael W Schuster, Roy Beveridge, Debra Frei-Lahr, et al.
The American Journal of Managed Care|May 28, 2015
Cost differential by site of service for cancer patients receiving chemotherapyJad Hayes, Russell J Hoverman, Matthew E Brow, et al.
Investigational New Drugs|October 13, 2010
A phase II open-label trial of bortezomib in patients with multiple myeloma who have undergone an autologous peripheral blood stem cell transplant and failed to achieve a complete responseRobert M Rifkin, Andrew Greenspan, John F Schwerkoske, et al.
Journal of Oncology Practice|January 3, 2012
Benchmarks for value in cancer care: an analysis of a large commercial populationMichael Kolodziej, J Russell Hoverman, Jody S Garey, et al.
Journal of Oncology Practice|November 2, 2011
Creating a process to standardize regimen order sets within an electronic health recordLeslie T Busby, Sheetal Sheth, Jody Garey, et al.
Population Health Management|October 30, 2019
Seeking Consensus on the Terminology of Value-Based Transformation Through use of a Delphi ProcessMarilyn M Schapira, Meredith Williams, Alan Balch, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of the National Comprehensive Cancer Network : JNCCN|May 25, 2013
Roundtable--the changing oncology landscape: evolution or revolution?Roy Beveridge, John Fox, Susan A Higgins, et al.
Experimental Hematology|September 13, 2002
The effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) on platelet recovery in breast cancer patients undergoing autologous bone marrow transplantationMichael W Schuster, Roy Beveridge, Debra Frei-Lahr, et al.
The American Journal of Managed Care|May 28, 2015
Cost differential by site of service for cancer patients receiving chemotherapyJad Hayes, Russell J Hoverman, Matthew E Brow, et al.
Investigational New Drugs|October 13, 2010
A phase II open-label trial of bortezomib in patients with multiple myeloma who have undergone an autologous peripheral blood stem cell transplant and failed to achieve a complete responseRobert M Rifkin, Andrew Greenspan, John F Schwerkoske, et al.
Journal of Oncology Practice|January 3, 2012
Benchmarks for value in cancer care: an analysis of a large commercial populationMichael Kolodziej, J Russell Hoverman, Jody S Garey, et al.
Journal of Oncology Practice|November 2, 2011
Creating a process to standardize regimen order sets within an electronic health recordLeslie T Busby, Sheetal Sheth, Jody Garey, et al.
Population Health Management|October 30, 2019
Seeking Consensus on the Terminology of Value-Based Transformation Through use of a Delphi ProcessMarilyn M Schapira, Meredith Williams, Alan Balch, et al.
Pageof 2